<- Go Home
NIOX Group Plc
NIOX Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis, monitoring, and management of asthma and COPD worldwide. The company offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device, sensors, individual disposable mouthpieces, and breathing handles for the measurement of fractional exhaled nitric oxide (FeNO) level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.
Market Cap
GBP 269.4M
Volume
1.0M
Cash and Equivalents
GBP 19.9M
EBITDA
GBP 14.3M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
GBP 33.7M
Profit Margin
69.20%
52 Week High
GBP 0.78
52 Week Low
GBP 0.54
Dividend
2.42%
Price / Book Value
3.96
Price / Earnings
39.03
Price / Tangible Book Value
6.44
Enterprise Value
GBP 250.5M
Enterprise Value / EBITDA
16.92
Operating Income
GBP 10.7M
Return on Equity
11.01%
Return on Assets
9.25
Cash and Short Term Investments
GBP 19.9M
Debt
GBP 1.0M
Equity
GBP 67.6M
Revenue
GBP 48.7M
Unlevered FCF
GBP 10.9M
Sector
Health Care Equipment and Supplies
Category
N/A